524711
VISTAPH
Start SIP
Invest Now
Start SIP in VISTAPH
Performance
- Low
- ₹8
- High
- ₹8
- 52 Week Low
- ₹7
- 52 Week High
- ₹13
- Open Price₹8
- Previous Close₹8
- Volume11,210
- 50 DMA₹8.25
- 100 DMA₹8.78
- 200 DMA₹9.57
Investment Returns
- Over 1 Month -9.52%
- Over 3 Month -22.58%
- Over 6 Month -31.42%
- Over 1 Year -30.2%
Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!
Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -6.9
- PEG Ratio
- 0.1
- Market Cap Cr
- 46
- P/B Ratio
- 1
- Average True Range
- 0.72
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.21
- RSI
- 44.24
- MFI
- 24.53
Vista Pharmaceuticals Financials
Vista Pharmaceuticals Technicals
EMA & SMA
Current Price
₹7.51
-0.6
(-7.4%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹7.88
- 50 Day
- ₹8.25
- 100 Day
- ₹8.78
- 200 Day
- ₹9.57
Resistance and Support
7.72
- R3 8.56
- R2 8.33
- R1 7.95
- S1 7.34
- S2 7.11
- S3 6.73
Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | (Revised) |
| 2025-11-13 | Quarterly Results | |
| 2025-08-13 | Quarterly Results | |
| 2025-05-30 | Audited Results | |
| 2025-02-19 | Preferential Issue of shares & Others | Inter-alia, to consider 1. Notice of the EGM for the approval of raising of funds. 2. Other business matters. |
Vista Pharmaceuticals F&O
About Vista Pharmaceuticals
- NSE Symbol
- VISTAPH
- BSE Symbol
- 524711
- Managing Director
- Mr. Murali Meraga
- ISIN
- INE427C01021
Similar Stocks to Vista Pharmaceuticals
Vista Pharmaceuticals FAQs
Vista Pharmaceuticals share price is ₹7 As on 08 February, 2026 | 23:38
The Market Cap of Vista Pharmaceuticals is ₹46.2 Cr As on 08 February, 2026 | 23:38
The P/E ratio of Vista Pharmaceuticals is -6.9 As on 08 February, 2026 | 23:38
The PB ratio of Vista Pharmaceuticals is 1 As on 08 February, 2026 | 23:38
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.